HCW Biologics Reports Q3 2026 Revenue of $55,463 and Net Loss of $3.2 Million
HCW Biologics reported third-quarter 2026 revenue of $55,463 and a net loss of $3.2 million, compared with revenue of $15,606 and a net loss of $4.6 million a year earlier. For the first nine months of 2026, revenue was $6.7 million and net loss was $5.0 million. The company also reported continued…